Earnings Feed
Start Free
Mirum Pharmaceuticals, Inc.·4

Jun 25, 5:15 PM ET

Vig Pamela 4

4 · Mirum Pharmaceuticals, Inc. · Filed Jun 25, 2024

Insider Transaction Report

Form 4
Period: 2024-06-24
Mirum Pharmaceuticals, Inc.MIRM
Vig Pamela
Chief Scientific Officer
Transactions
  • Sale

    Common Stock

    2024-06-24$34.00/sh−30,559$1,039,006→ 27,406 total
  • Exercise/Conversion

    Common Stock

    2024-06-24$2.94/sh+30,559$89,721→ 57,965 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2024-06-24−30,559→ 125,691 total
    Exercise: $2.94Exp: 2029-03-11→ Common Stock (30,559 underlying)
Holdings

  • Common Stock

    (indirect: By Trust)
    75,000
Footnotes (2)
  • [F1]Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted in March 2024.
  • [F2]The stock option is fully vested.

Documents

1 file
  • 4
    form4-06252024_090650.xmlPrimary